Daewoong Pharmaceutical, operating profit of 17 billion won last year… 62% decrease from the previous year
Ministry of Food and Drug Safety “A domestic antibody treatment developer reveals plans to apply for use approval within this month”
Daewoong Pharmaceutical’s Hoy Star tablet phase 2a main evaluation variable not satisfied…2b/3 phase progress
